The results in rodent models of atherosclerosis are not interchangeable. The influence of diet and strain

Atherosclerosis

Volumn 195, Issue 2, 2007, Pages

  Joven, Jorge ^a   Rull, Anna ^a   Ferré, Natàlia ^b   Escolà Gil, Joan Carles ^c   Marsillach, Judit ^a   Coll, Blai ^a   Alonso Villaverde, Carlos ^a   Aragones, Gerard ^a   Claria, Joan ^b   Camps, Jordi ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Apo E deficient mice; Arteriosclerosis; Dietary cholesterol; Glucose tolerance; Hepatotoxicity; Inflammation; LDLr deficient mice; Steatohepatitis

Indexed keywords

CHOLESTEROL;

ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CONTROLLED STUDY; DIET; DISEASE COURSE; FEEDING BEHAVIOR; GENE EXPRESSION; GLUCOSE TOLERANCE; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 36048989420     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.06.012     Document Type: Article

References (29)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Tous M., Ferre N., Camps J., Riu F., and Joven J. Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol Cell Biochem 268 (2005) 53-58
3. Daugherty A., and Rateri D.L. Development of experimental designs for atherosclerosis studies in mice. Methods 36 (2005) 129-138
4. Breslow J.L. Mouse models of atherosclerosis. Science 272 (1996) 685-688
5. Zhang S.H., Reddick R.L., Piedrahita J.A., and Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258 (1992) 468-471
6. Plump A.S., Smith J.D., Hayek T., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71 (1992) 343-353
7. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., and Burns D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low-density lipoprotein receptor-negative mice. J Clin Invest 93 (1994) 1885-1893
8. Osada J., Joven J., and Maeda N. The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis. Curr Opin Lipidol 11 (2000) 25-29
9. Calleja L., Paris M.A., Paul A., et al. Low-cholesterol and high-fat diets reduce atherosclerotic lesion development in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 10 (1999) 2368-2375
10. Lichtman A.H., Clinton S.K., Iiyama K., et al. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 8 (1999) 1938-1944
11. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1 (1994) 133-140
12. Ishibashi S., Herz J., Maeda N., Goldstein J.L., and Brown M.S. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low-density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci USA 91 (1994) 4431-4435
13. Vergnes L., Phan J., Strauss M., Tafuri S., and Reue K. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem 278 (2003) 42774-42784
14. Tous M., Ferre N., Rull A., et al. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun 340 (2006) 1078-1084
15. Veillard N.R., Steffens S., Burger F., Pelli G., and Mach F. Differential expression patterns of proinflammatory and anti-inflammatory mediators during atherogenesis in mice. Arterioscler Thromb Vasc Biol 24 (2004) 2339-2344
16. Wuttge D.M., Sirsjo A., Eriksson P., and Stemme S. Gene expression in atherosclerotic lesion of ApoE deficient mice. Mol Med 7 (2001) 383-392
17. Targher G., Bertolini L., Padovani R., et al. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. J Endocrinol Invest 29 (2006) 55-60
18. Escola-Gil J.C., Julve J., Marzal-Casacuberta A., et al. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia. J Lipid Res 41 (2000) 1328-1338
19. Paigen B., Morrow A., Holmes P.A., Mitchell D., and Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68 (1987) 231-240
20. Repa J.J., Turley S.D., Lobaccaro J.A., et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 (2000) 1524-1529
21. Dietschy J.M., and Turley S.D. Control of cholesterol turnover in the mouse. J Biol Chem. 277 (2002) 3801-3804
22. Gan J., Katagiri H., Ishigaki Y., et al. Involvement of Apolipoprotein E in excess fat accumulation and insulin resistance. Diabetes 56 (2007) 24-33
23. Schreyer S.A., Vick C., Lystig T., Mystkowsky P., and Leboeuf R. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab. 282 (2002) E207-E214
24. Merat S., Casanada F., Sutphin M., Palinski W., and Reaven P. Western-type diets induce insulin resistance in LDL receptor deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol 19 (1999) 1223-1230
25. Damas J.K., Boullier A., Waehre T., et al. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. Arterioscler Thromb Vasc Biol 25 (2005) 2567-2572
26. Chi H., Messas E., Levine R.A., Graves D.T., and Amar S. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Circulation 110 (2004) 1678-1685
27. Ogletree M.L. Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 46 (1987) 133-138
28. Marshall S. The hexosamine-signalling pathway: a new road to drug discovery. Curr Opin Endocrinol Diabetes 9 (2002) 160-167
29. Lee C.H., Olson P., Hevener A., et al. PPARδ regulates glucose metabolism and insulin sensitivity. PNAS 103 (2006) 3444-3449